Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

CR Chapman, GP Quinn, HM Natri… - The American Journal …, 2023 - Taylor & Francis
Harms and risks to groups and third-parties can be significant in the context of research,
particularly in data-centric studies involving genomic, artificial intelligence, and/or machine …
被引用次数：1 相关文章

Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

CR Chapman, GP Quinn, HM Natri… - The American Journal …, 2023 - europepmc.org
Harms and risks to groups and third-parties can be significant in the context of research,
particularly in data-centric studies involving genomic, artificial intelligence, and/or machine …

Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

CR Chapman, GP Quinn, HM Natri… - … American journal of … - pubmed.ncbi.nlm.nih.gov
Harms and risks to groups and third-parties can be significant in the context of research,
particularly in data-centric studies involving genomic, artificial intelligence, and/or machine …

Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

CR Chapman, GP Quinn, HM Natri, C Berrios, P Dwyer… - philpapers.org
Harms and risks to groups and third-parties can be significant in the context of research,
particularly in data-centric studies involving genomic, artificial intelligence, and/or machine …